Business Wire News

A bit more information

TASKUS ALERT: Bragar Eagel & Squire, P.C. is Investigating TaskUs, Inc. on Behalf of TaskUs Stockholders and Encourages Investors to Contact the Firm

22nd January 2022
NEW YORK--(BUSINESS WIRE)--#Class--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against TaskUs, Inc. (“TaskUs” or the “Company”) (NASDAQ: TASK) on behalf of TaskUs stockholders. Our investigation concerns whether TaskUs has violated the federal securities laws and/or engaged in other unlawful business practices. Click here to participate in […]
Read full article

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Bright Health Group, Inc. (BHG)

21st January 2022
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming March 7, 2022 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Bright Health Group, Inc. (“Bright Health” or the “Company”) (NYSE: BHG): (a) common stock pursuant and/or traceable to […]
Read full article

SHAREHOLDER ALERT: Robbins LLP Investigates Aligos Therapeutics, Inc. (ALGS) on Behalf of Shareholders

21st January 2022
SAN DIEGO--(BUSINESS WIRE)--$ALGS #classaction--Shareholder rights law firm Robbins LLP is investigating Aligos Therapeutics, Inc. (NASDAQ: ALGS) to determine whether certain Aligos officers and directors violated securities laws and breached fiduciary duties to shareholders. Aligos, a clinical-stage biopharmaceutical company, develops novel therapeutics to address unmet medical needs in viral and liver diseases. Its lead drug candidate […]
Read full article

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of NRx Pharmaceuticals, Inc. (NRXP) on Behalf of Investors

21st January 2022
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of NRx Pharmaceuticals, Inc. (“NRx” or the “Company”) (NASDAQ: NRXP) investors concerning the Company’s possible violations of the federal securities laws. If you suffered a loss on your NRx investments […]
Read full article

KLDiscovery Introduces Nebula Singularity™ Global Subscription Service

21st January 2022
MCLEAN, Va.--(BUSINESS WIRE)--KLDiscovery Inc. ("KLDiscovery", “KLD” or the “Company”), a leading provider of global electronic discovery, information governance and data recovery technology solutions, announced the launch of Nebula Singularity, its premier subscription service that was designed to benefit corporations seeking to globalize and standardize their eDiscovery processes. Nebula Singularity is a simple, one-touch licensing option […]
Read full article

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of TaskUs, Inc. (TASK) on Behalf of Investors

21st January 2022
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of TaskUs, Inc. (“TaskUs” or the “Company”) (NASDAQ: TASK) investors concerning the Company’s possible violations of federal securities laws. On January 20, 2022, Spruce Point Capital Management, LLC published a report alleging, among other things, that TaskUs “has a pattern of exaggerated […]
Read full article

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of NRx Pharmaceuticals, Inc. (NRXP) on Behalf of Investors

20th January 2022
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of NRx Pharmaceuticals, Inc. (“NRx” or the “Company”) (NASDAQ: NRXP) investors concerning the Company’s possible violations of the federal securities laws. In June 2021, NRx announced that it filed an application with U.S. Food and Drug Administration (“FDA”) requesting Emergency Use Authorization […]
Read full article

INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Oak Street Health, Inc. (OSH) Investors and Encourages Investors to Contact the Firm Before March 14, 2022

20th January 2022
NEW YORK--(BUSINESS WIRE)--$OSH--The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Northern District of Illinois on behalf of those who acquired Oak Street Health, Inc. (“Oak Street” or the “Company”) (NYSE: OSH) securities from August 6, 2020 through November 8, […]
Read full article

EHEALTH ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against eHealth, Inc. and Encourages Investors to Contact the Firm

20th January 2022
NEW YORK--(BUSINESS WIRE)--#Class--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against eHealth, Inc. (“eHealth” or the “Company”) (NASDAQ: EHTH) in the United States District Court for the Northern District of California on behalf of all persons and entities who purchased or […]
Read full article

NRX ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against NRx Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm

20th January 2022
NEW YORK--(BUSINESS WIRE)--#Class--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against NRx Pharmaceuticals, Inc. (“NRx” or the “Company”) (NASDAQ: NRXP, NRXPW) in the United States District Court for the District of Delaware on behalf of all persons and entities who purchased […]
Read full article
1 58 59 60 61 62 94
Connect with LM

About Lawyer Monthly

Lawyer Monthly is a news website and monthly legal publication with content that is entirely defined by the significant legal news from around the world.